PP1 (RMML-00120837)
Cat. No.: RMML-00120837
Category: Inhibitors & Activators
INQUIRY
1 mg
5 mg
PP1 is a reversible inhibitor of the SRC family of tyrosine kinases. It inhibits LCK, FYN, HCK and SRC with IC₅₀ values of 5, 6, 20 and 170 nM, respectively. It is relatively selective for SRC family kinases versus other kinases, inhibiting epidermal growth factor receptor. PP1 also blocks TGF-β-mediated cellular responses by directly inhibiting type I TGF-β receptors. Enables reprogramming of mouse embryonic fibroblasts to induced pluripotent stem cells in the absence of reprogramming factor SOX2. Blocks TGF-β-mediated migration of primary non-small cell lung carcinoma cells and pancreatic ductal adenocarcinoma cell lines. Induces apoptosis in non-small cell lung cancer cell lines.
Product Features
Purity | ≥ 98% |
---|---|
Applications | Reprogramming |
Cross Reactivity | Human, Mouse, Non-Human Primate, Other, Rat |
Compound Information
Target Pathways | Tyrosine Kinase |
---|---|
CAS Number | 172889-26-8 |
Molecular Formula | C₁₆H₁₉N₅ |
Storage & Shipping
Handling | Refer to SDS for further information. |
---|
For research use only. Not for clinical use.